318 related articles for article (PubMed ID: 9819070)
21. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
Moroz G; Rosenbaum JF
J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
[TBL] [Abstract][Full Text] [Related]
23. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
[TBL] [Abstract][Full Text] [Related]
24. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
[TBL] [Abstract][Full Text] [Related]
25. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
Lepola U; Arató M; Zhu Y; Austin C
J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
27. Sertraline treatment of panic disorder: results of a long-term study.
Rapaport MH; Wolkow R; Rubin A; Hackett E; Pollack M; Ota KY
Acta Psychiatr Scand; 2001 Oct; 104(4):289-98. PubMed ID: 11722304
[TBL] [Abstract][Full Text] [Related]
28. Switching from imipramine to sertraline in panic disorder.
Mavissakalian MR
J Psychiatr Pract; 2004 Mar; 10(2):88-94. PubMed ID: 15330404
[TBL] [Abstract][Full Text] [Related]
29. Sertraline and alprazolam in the treatment of panic desorder.
Fiseković S; Loga-Zec S
Bosn J Basic Med Sci; 2005 May; 5(2):78-81. PubMed ID: 16053461
[TBL] [Abstract][Full Text] [Related]
30. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
[TBL] [Abstract][Full Text] [Related]
31. Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.
Ferguson JM; Khan A; Mangano R; Entsuah R; Tzanis E
J Clin Psychiatry; 2007 Jan; 68(1):58-68. PubMed ID: 17284131
[TBL] [Abstract][Full Text] [Related]
32. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C
J Clin Psychiatry; 2006 Jan; 67(1):15-22. PubMed ID: 16426083
[TBL] [Abstract][Full Text] [Related]
33. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
Stahl SM; Gergel I; Li D
J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
[TBL] [Abstract][Full Text] [Related]
34. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
Mavissakalian MR
Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
[TBL] [Abstract][Full Text] [Related]
35. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
Davidson JR; Rothbaum BO; van der Kolk BA; Sikes CR; Farfel GM
Arch Gen Psychiatry; 2001 May; 58(5):485-92. PubMed ID: 11343529
[TBL] [Abstract][Full Text] [Related]
36. Placebo-controlled trial of sertraline in the treatment of binge eating disorder.
McElroy SL; Casuto LS; Nelson EB; Lake KA; Soutullo CA; Keck PE; Hudson JI
Am J Psychiatry; 2000 Jun; 157(6):1004-6. PubMed ID: 10831483
[TBL] [Abstract][Full Text] [Related]
37. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.
Versiani M; Cassano G; Perugi G; Benedetti A; Mastalli L; Nardi A; Savino M
J Clin Psychiatry; 2002 Jan; 63(1):31-7. PubMed ID: 11838623
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.
Sheehan DV; Burnham DB; Iyengar MK; Perera P;
J Clin Psychiatry; 2005 Jan; 66(1):34-40. PubMed ID: 15669886
[TBL] [Abstract][Full Text] [Related]
39. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
[TBL] [Abstract][Full Text] [Related]
40. A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome.
O'Reardon JP; Allison KC; Martino NS; Lundgren JD; Heo M; Stunkard AJ
Am J Psychiatry; 2006 May; 163(5):893-8. PubMed ID: 16648332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
